These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15511333)

  • 1. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction.
    Kettel LM; Scholl G; Bonaventura L; Pang S; Sacks P; Chantilis S; Mahony M;
    Reprod Biomed Online; 2004 Oct; 9(4):373-80. PubMed ID: 15511333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation.
    Pang S; Kaplan B; Karande V; Westphal LM; Scott R; Givens C; Sacks P;
    Reprod Biomed Online; 2003 Oct; 7(3):319-26. PubMed ID: 14653893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI.
    Platteau P; Laurent E; Albano C; Osmanagaoglu K; Vernaeve V; Tournaye H; Camus M; Van Steirteghem A; Devroey P
    Hum Reprod; 2003 Jun; 18(6):1200-4. PubMed ID: 12773446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pen injection device for self-administration of recombinant follicle-stimulating hormone for fertility treatments.
    Pang SC
    Expert Rev Med Devices; 2005 Jan; 2(1):27-32. PubMed ID: 16293025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
    Porter R; Kissel C; Saunders H; Keck C
    Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of follitropin-beta administered by a pen device with conventional syringe in an ART programme - a retrospective study.
    Rama Raju GA; Suryanarayana K; Jaya Prakash G; Murali Krishna K
    J Clin Pharm Ther; 2008 Aug; 33(4):401-7. PubMed ID: 18613858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
    J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective comparison of clinical outcomes and satisfaction using reconstituted recombinant gonadotropins (rFSH) or cartridge rFSH with a pen device in donor oocyte cycles.
    Christianson MS; Barker MA; Schouweiler C; Lindheim SR
    Curr Med Res Opin; 2007 Apr; 23(4):865-70. PubMed ID: 17407643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy.
    López E; Gunby J; Daya S; Parrilla JJ; Abad L; Balasch J
    Reprod Biomed Online; 2004 Oct; 9(4):382-90. PubMed ID: 15511336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study.
    Strowitzki T; Kuczynski W; Mueller A; Bias P
    Reprod Biol Endocrinol; 2016 Jun; 14(1):31. PubMed ID: 27287439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.
    Welcker JT; Nawroth F; Bilger W
    Reprod Biol Endocrinol; 2010 Sep; 8():111. PubMed ID: 20843323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of the administration of follitropin-beta with a pen device.
    Bruynesteyn K; Bonsel GJ; Braat DD; Fauser BC; Devroey P; van Genugten ML
    Reprod Biomed Online; 2005 Jul; 11(1):26-35. PubMed ID: 16102283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
    Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).
    Lenton E; Soltan A; Hewitt J; Thomson A; Davies W; Ashraf N; Sharma V; Jenner L; Ledger W; McVeigh E
    Hum Reprod; 2000 May; 15(5):1021-7. PubMed ID: 10783345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization].
    Chen LN; Quan S; Li H; Yang XP; Chen SM; Zhang XY; Lin L; Xing FQ; Chen SL; Wan ZJ; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):100-4. PubMed ID: 19218125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comfort, ease of use and practicality of the pen injector for follitropin α for assisted reproduction: an observational post-marketing study in Egypt.
    Yehia M; El-Khayat W; Kortam A; Mowafy AH; Aziz Khalifa AA; Awad A; Khattab S
    Curr Med Res Opin; 2013 Nov; 29(11):1429-34. PubMed ID: 23899053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
    Abd-Elaziz K; Duijkers I; Stöckl L; Dietrich B; Klipping C; Eckert K; Goletz S
    Hum Reprod; 2017 Aug; 32(8):1639-1647. PubMed ID: 28591833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.